SL
BTMD icon

Sentinus LLC’s Biote Corp BTMD Stock Holding History

Sentinus LLC’s Portfolio BTMD Stock Details BTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$48.4K Sell
35,865
-110,385
-75% -$222K ﹤0.01% 590
2025
Q4 		$380K Buy
+146,250
New +$400K 0.04% 373

Other funds holding BTMD

3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
BP
Bandera Partners New York $221M AUM 10.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GC
Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Sentinus LLC's BTMD Position: Q1 2026 in Review

Sentinus LLC reduced its Biote Corp (BTMD) stake by 75% in Q1 2026, selling an estimated $222K and leaving 35,865 shares worth $48.4K. The position accounts for ﹤0.01% of the portfolio, ranked #590.

Sentinus LLC first reported a position in BTMD in Q4 2025 and has held it in 2 quarters since. The position peaked at $380K in Q4 2025. 84 funds tracked by Wall St. Rank hold BTMD as of Q1 2026.

  • Sentinus LLC held 35,865 shares of Biote Corp worth $48.4K as of Q1 2026.
  • Sentinus LLC sold 110,385 Biote Corp shares in Q1 2026, an estimated $222K.
  • Biote Corp made up ﹤0.01% of Sentinus LLC's portfolio in Q1 2026, its #590 holding.
  • Sentinus LLC first reported a position in Biote Corp in Q4 2025 and has held it in 2 quarters since.
  • Sentinus LLC's Biote Corp position peaked at $380K in Q4 2025.
  • 84 funds tracked by Wall St. Rank held Biote Corp as of Q1 2026.

Based on Sentinus LLC's 13F filing for Q1 2026, filed 6 May 2026.